Searchable abstracts of presentations at key conferences in endocrinology

ea0014oc12.3 | Diabetes | ECE2007

Adhesion molecules two years after gestational diabetes

Prikoszovich Thomas , Pacini Giovanni , Winzer Christine , Luger Anton , Wagner Oswald , Kautzky-Willer Alexandra

Objectives: We investigated in women with prior GD (pGD) at risk of diabetes and premature atherosclerosis in comparison to women with normal glucose tolerance during and after pregnancy (C) parameters of inflammation, endothelial dysfunction and glucose tolerance in a follow-up study.Methods: 119 pGD and 41 C underwent an oral glucose tolerance test 3 months, 1 and 2 years after delivery with measurements of plasma concentrations of circulating adhesion...

ea0016p505 | Obesity | ECE2008

Plasma osteopontin correlates with insulin resistance in obese subjects, but increases following bariatric surgery parallel to other markers of bone turnover

Riedl Michaela , Vila Greisa , Maier Christina , Handisurya Ammon , Shakeri-Manesch Soheila , Prager Gerhard , Wagner Oswald , Kautzky-Willer Alexandra , Clodi Martin , Luger Anton

Osteopontin (OPN) is a multifunctional glycoprotein implicated, among others, in bone metabolism, cardiovascular disease, diabetes and obesity. It promotes inflammation and insulin resistance. Osteopontin is elevated in the plasma and adipose tissue of obese subjects and decreases upon diet induced weight loss. Here we investigated the effect of bariatric surgery on plasma OPN concentrations in morbidly obese patients. 40 obese patients aged 43.1±1.8 years were recruited ...

ea0014p171 | (1) | ECE2007

Muscle mitochondrial function is impaired in patients with prior acromegaly

Szendrödi Julia , Zwettler Elisabeth , Schmid Albrecht Ingo , Chmelik Marek , Pacini Giovanni , Kacerovsky Gertrud , Schnack Christoph , Schernthaner Guntram , Wagner Oswald , Klaushofer Klaus , Roden Michael

Acromegaly is amongst other symptoms associated with myopathy, alterations of energy expenditure and insulin action which are mediated by growth hormone (GH) and insulin-like growth factors (IGFs). It is unclear to which extent these abnormalities remain after treatment. Thus, we examined glucose metabolism, intracellular fat deposition and mitochondrial function in patients with prior acromegaly (AM).Six AM (4f/2 m, age: 49±10 years, body mass inde...